Kiniksa Pharmaceuticals Ltd (KNSA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$7.47B
EV to revenue ratio (TTM)
7.61
EV to ebitda
54.39
Financial Performance
Revenue (TTM)
$0.95B
Gross profit (TTM)
$0.51B
EBITDA
$0.13B
Profitability
Operating margin (TTM)
19.00%
Profit margin
11.60%
Return on assets (TTM)
9.62%
Return on equity (TTM)
17.60%
Per Share Metrics
Revenue per share (TTM)
$12.27
EPS
$1.27
Diluted EPS (TTM)
$1.27
Book value
$9.05
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
74.82
Trailing P/E
74.82
Forward P/E
62.11
PEG ratio
n/a
Price to sales ratio (TTM)
7.89
Price to book ratio (TTM)
10.93
Growth
Quarterly earnings growth (YoY)
58.10%
Quarterly revenue growth (YoY)
143.50%
Analyst Sentiment
Strong buy
1
Buy
7
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.08